Role evidence
Usage summary
Strongest role: Inclusion Required
Inclusion-required count: 8
Treatment-assignment count: 0
Stratification count: 0
Manual Review Required
PD-L1 expression
gastric cancer · Therapy Not Normalized
PD-L1 expression is flagged as manual review required because public trials show inclusion required evidence in 12 contexts. FDA CDx context exists.
Threshold snippets
Fragmentation view
Threshold count: 5
Common snippets: dMMR | dMMR | dMMR
Threshold label: Moderate
FDA CDx context
Mapping summary
CDx label: Fda Cdx Context Exists
CDx maturity score: 5/5
Confidence: Low
Patent-density signal
Diagnostic appendix
Signal count: 1
Recent signals: 1
Density label: Low
Source links
Evidence paths
https://clinicaltrials.gov/study/NCT07394205 | https://clinicaltrials.gov/study/NCT06925243 | https://clinicaltrials.gov/study/NCT05348161 | https://clinicaltrials.gov/study/NCT06487429 | https://clinicaltrials.gov/study/NCT06939452 | https://clinicaltrials.gov/study/NCT05625737 | https://clinicaltrials.gov/study/NCT06059495 | https://clinicaltrials.gov/study/NCT07492615 | https://clinicaltrials.gov/study/NCT06519591 | https://clinicaltrials.gov/study/NCT06084286 | https://clinicaltrials.gov/study/NCT05393986 | https://clinicaltrials.gov/study/NCT05952375